Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.54 |
| ▸ | NPY4R | P50391 | 11/20 | 0.47 |
| ▸ | NPY1R | P25929 | 6/20 | 0.47 |
| ▸ | NPY2R | P49146 | 4/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.40 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31171160 | 1.00 | FOLH1 (0.54) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29902836 | 1.00 | FOLH1 (0.54) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL27613292 | 1.00 | FOLH1 (0.54) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30414248 | 1.00 | FOLH1 (0.54) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30045741 | 1.00 | FOLH1 (0.54) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31420018 | 1.00 | FOLH1 (0.54) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31452998 | 1.00 | FOLH1 (0.54) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30423428 | 1.00 | FOLH1 (0.54) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30412991 | 0.97 | FOLH1 (0.51) | FOLH1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29874727 | 0.97 | FOLH1 (0.52) | FOLH1NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0502007-A4 | METHOD FOR REDUCING BLOOD CHOLESTEROL USING ARGININE | — | 1992-11-19 | — | — | EP | claimed |
| US-5157022-A | Administering arginine nicotinate and di- and tripeptides of arginine | BARBUL ADRIAN (US) | 1992-10-20 | — | — | US | claimed |
| EP-0502007-A1 | ARGININE NICOTINATE FOR REDUCING BLOOD CHOLESTEROL | BARBUL, Adrian (US) | 1992-09-09 | — | — | EP | claimed |
| WO-1991007188-A1 | METHOD FOR REDUCING BLOOD CHOLESTEROL USING ARGININE | BARBUL ADRIAN (US) | 1991-05-30 | — | — | WO | claimed |
| EP-4731002-A2 | SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS | Tenfold Technologies, LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024263793-A2 | SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTS | Tenfold Technologies, LLC (US) | 2024-12-26 | — | — | WO | disclosed |
| US-20080145424-A1 | Sustained release L-arginine formulations and methods of manufacture and use | ENOS PHRAMACEUTICALS, INC. (US) | 2008-06-19 | — | — | US | disclosed |
| CN-101184510-A | Methods of treating various disorders by administering sustained release L-arginine | ENOS PHARMACEUTICALS INC (US) | 2008-05-21 | — | — | CN | disclosed |
| EP-1846037-A4 | METHODS OF TREATING VARIOUS CONDITIONS BY ADMINISTRATION OF SUSTAINED RELEASE L-ARGININE | PALMETTO PHARMACEUTICALS LLC (US) | 2008-03-12 | — | — | EP | disclosed |
| EP-1874277-A1 | SUSTAINED RELEASE L-ARGININE FORMULATIONS AND METHODS OF MANUFACTURE AND USE | Palmetto Pharmaceuticals, LLC (US) | 2008-01-09 | — | — | EP | disclosed |
| EP-1846037-A1 | METHODS OF TREATING VARIOUS CONDITIONS BY ADMINISTRATION OF SUSTAINED RELEASE L-ARGININE | Enos Pharmaceuticals, Inc. (US) | 2007-10-24 | — | — | EP | disclosed |
| US-20070219208-A1 | Methods for Treating Cancer | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-09-20 | — | — | US | disclosed |
| US-20060029668-A1 | Sustained release L-arginine formulations and methods of manufacture and use | ENOS PHARMACEUTICALS, INC. | 2006-02-09 | — | — | US | disclosed |
| CN-1731985-A | Sustained release L-arginine formulations and methods of production and use thereof | ENOS PHARMACEUTICALS INC (US) | 2006-02-08 | — | — | CN | disclosed |
| US-20050288372-A1 | Methods of treating various conditions by administration of sustained released L-Arginine | ENOS PHARMACEUTICALS, INC. (US) | 2005-12-29 | — | — | US | disclosed |
| US-20050287210-A1 | Sustained release L-arginine formulations and methods of manufacture and use | ENOS PHARMACEUTICALS, INC. (US) | 2005-12-29 | — | — | US | disclosed |
| US-20050288373-A1 | Methods of treating various conditions by administration of sustained release L-arginine | PALMETTO PHARMACEUTICALS, LLC (GE) | 2005-12-29 | — | — | US | disclosed |
| WO-2003094909-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF INTERMITTENT CLAUDICATION OR ALZHEIMER'S DISEASE | ENOS PHARMACEUTICALS, INC. (US) | 2003-11-20 | — | — | WO | disclosed |
| US-6475530-B1 | Methods and compositions for producing weight loss | HSBC BANK CANADA (CA) | 2002-11-05 | — | — | US | disclosed |
| US-5157022-A | Administering arginine nicotinate and di- and tripeptides of arginine | BARBUL ADRIAN (US) | 1992-10-20 | — | — | US | disclosed |